These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25843618)

  • 1. Innate immune evasion by filoviruses.
    Basler CF
    Virology; 2015 May; 479-480():122-30. PubMed ID: 25843618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
    Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filoviral immune evasion mechanisms.
    Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
    Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.
    Martinez O; Leung LW; Basler CF
    Antiviral Res; 2012 Mar; 93(3):416-28. PubMed ID: 22333482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evasion of interferon responses by Ebola and Marburg viruses.
    Basler CF; Amarasinghe GK
    J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
    Yen BC; Basler CF
    J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
    Guito JC; Albariño CG; Chakrabarti AK; Towner JS
    Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
    Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
    Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.
    Martines RB; Ng DL; Greer PW; Rollin PE; Zaki SR
    J Pathol; 2015 Jan; 235(2):153-74. PubMed ID: 25297522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.
    Ramanan P; Edwards MR; Shabman RS; Leung DW; Endlich-Frazier AC; Borek DM; Otwinowski Z; Liu G; Huh J; Basler CF; Amarasinghe GK
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20661-6. PubMed ID: 23185024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus.
    Messaoudi I; Amarasinghe GK; Basler CF
    Nat Rev Microbiol; 2015 Nov; 13(11):663-76. PubMed ID: 26439085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of filoviral haemorrhagic fevers.
    Mahanty S; Bray M
    Lancet Infect Dis; 2004 Aug; 4(8):487-98. PubMed ID: 15288821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad and Temperature Independent Replication Potential of Filoviruses on Cells Derived From Old and New World Bat Species.
    Miller MR; McMinn RJ; Misra V; Schountz T; Müller MA; Kurth A; Munster VJ
    J Infect Dis; 2016 Oct; 214(suppl 3):S297-S302. PubMed ID: 27354372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Ebola and Marburg viruses battle the immune system.
    Mohamadzadeh M; Chen L; Schmaljohn AL
    Nat Rev Immunol; 2007 Jul; 7(7):556-67. PubMed ID: 17589545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion.
    Luthra P; Aguirre S; Yen BC; Pietzsch CA; Sanchez-Aparicio MT; Tigabu B; Morlock LK; García-Sastre A; Leung DW; Williams NS; Fernandez-Sesma A; Bukreyev A; Basler CF
    mBio; 2017 Apr; 8(2):. PubMed ID: 28377530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of host immune responses in Ebola virus infections.
    Wong G; Kobinger GP; Qiu X
    Expert Rev Clin Immunol; 2014 Jun; 10(6):781-90. PubMed ID: 24742338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.
    Mohamadzadeh M; Coberley SS; Olinger GG; Kalina WV; Ruthel G; Fuller CL; Swenson DL; Pratt WD; Kuhns DB; Schmaljohn AL
    J Virol; 2006 Jul; 80(14):7235-44. PubMed ID: 16809329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.
    O'Hearn A; Wang M; Cheng H; Lear-Rooney CM; Koning K; Rumschlag-Booms E; Varhegyi E; Olinger G; Rong L
    J Virol; 2015 May; 89(10):5441-9. PubMed ID: 25741008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyro3 family-mediated cell entry of Ebola and Marburg viruses.
    Shimojima M; Takada A; Ebihara H; Neumann G; Fujioka K; Irimura T; Jones S; Feldmann H; Kawaoka Y
    J Virol; 2006 Oct; 80(20):10109-16. PubMed ID: 17005688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune evasion in ebolavirus infections.
    Audet J; Kobinger GP
    Viral Immunol; 2015 Feb; 28(1):10-8. PubMed ID: 25396298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.